Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- ChecktodayChange DetectedThe record presents the completed DAPA ACT HF-TIMI 68 trial of dapagliflozin versus placebo in patients hospitalized for acute heart failure, including its eligibility criteria, treatment arms, outcome measures, and posted results and publications.SummaryDifference48%

- Check7 days agoChange DetectedThe footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner was added announcing NIH website changes and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check21 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check49 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the previous study record content and navigation. This indicates access is blocked rather than displaying the study details.SummaryDifference18%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.